The growing disparities in cancer treatment between high- and low-income countries are becoming more pronounced, with significant inequalities in the cost and availability of cancer drugs globally. Predictions indicate that by 2040 the world will witness an estimated 28.4 million new cancer cases
In a significant stride for cancer detection, Mursla Bio recently announced encouraging results from its multi-center clinical study, MEV01, which focuses on the early detection of liver cancer, particularly Hepatocellular Carcinoma (HCC), using their innovative dynamic biopsy technology. Conducted
Head and neck cancers rank as the seventh most common type of cancer globally, significantly impacting smokers, drinkers, and individuals with HPV infections. Cisplatin, a standard chemotherapy drug, coupled with radiation therapy, remains the gold standard for treating these cancers. However, over
Glioblastoma, one of the most aggressive and lethal forms of brain cancer, presents a significant challenge to medical professionals due to its resistance to standard therapies. The complexity of its cellular structure and its ability to evade the immune system make it particularly difficult to
Recent research has uncovered a startling discovery: certain rare genetic mutations in the breast cells of healthy women may be early indicators of breast cancer development. This groundbreaking study, conducted by researchers from the University of British Columbia (UBC), BC Cancer, Harvard
The burgeoning potential of radiopharmaceuticals in precision oncology is reshaping the landscape of cancer treatment, marked by rapid advancements and considerable investment opportunities. These sophisticated compounds, which combine radioactive substances with targeted molecules, not only
